Market capitalization | $987.25m |
Enterprise Value | $982.91m |
PER (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 7.16 |
P/S ratio (TTM) P/S ratio | 7.19 |
P/B ratio (TTM) P/B ratio | 2.94 |
Sales growth (TTM) Sales growth | -15.89% |
Turnover (TTM) Turnover | $137.30m |
As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.
9 Analysts have issued a BioLife Solutions, Inc. forecast:
9 Analysts have issued a BioLife Solutions, Inc. forecast:
Mar '24 |
+/-
%
|
||
Turnover | 137 137 |
16%
16%
|
|
Gross income | 41 41 |
15%
15%
|
|
EBITDA | -43 -43 |
93%
93%
|
EBIT (operating result) EBIT | -55 -55 |
33%
33%
|
Net profit | -63 -63 |
57%
57%
|
Figures in millions USD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.
Head office | United States |
CEO | Roderick Greef |
Employees | 414 |
Founded | 1987 |
Website | www.biolifesolutions.com |
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.